The EU announced on Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine.
The European Commission, the bloc’s executive arm which negotiated the agreement, said it would allow all 27 member countries to purchase the vaccine once it was proven to be safe and effective.
For more coronavirus news, visit our dedicated page.
In a related development, the US government will pay $2.1 billion to Sanofi and GlaxoSmithKline for COVID-19 vaccines to cover 50 million people and to underwrite the drug makers’ testing and manufacturing, the companies said on Friday.
Coronavirus: EU countries close in on $2.1 trillion budget and COVID-19 recovery fundWeary European Union leaders finally were closing in on an unprecedented 1.82 trillion euro ($2.1 trillion) budget and coronavirus recovery fund early ... Coronavirus
Spain welcomes $824 bln EU coronavirus fund plan as good basis for talksThe Spanish government said on Wednesday the European Union’s proposal for a 750 billion euro ($824 bln) coronavirus recovery fund would serve as a ... Coronavirus
French coronavirus drugmaker Sanofi pushes for COVID-19 vaccine approvalFrench drugmaker Sanofi expects to win approval for a COVID-19 vaccine in the first half of next year as it strengthens a pact with Translate Bio Inc. ... Coronavirus